Subscriber login
ADVERTISE HERE 

DrugPatentWatch

Pharmaceutical Innovation Dashboard

Your Source for Pharmaceutical Industry Intelligence

Ultimate Plan

compare plans
Drug therapeutic classDrug patent expirationsPatent expiration datesAnnual drug sales
$475 / One Month $1,895 / One Year
One MonthOne Year
Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Drug Patent Expirations in March 2010

*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent Number Patent Expiration
AZASITEInspireazithromycin5,192,535Mar 9, 2010
SOLAGEStiefel Labs Incmequinol; tretinoin5,470,567Mar 19, 2010
PYLERAAxcan Scandipharmbismuth subcitrate potassium; metronidazole; tetracycline5,476,669Mar 23, 2010
KADIANActavis Elizabethmorphine sulfate5,378,474Mar 23, 2010
PYLERAAxcan Scandipharmbismuth subcitrate potassium; metronidazole; tetracycline5,196,205Mar 23, 2010
EMBEDAAlpharma Kingmorphine sulfate; naltrexone hydrochloride5,378,474Mar 23, 2010
CADUETPfizeramlodipine besylate; atorvastatin calcium4,681,893*PEDMar 24, 2010
LIPITORPfizeratorvastatin calcium4,681,893*PEDMar 24, 2010
CARDENE SREkr Therapnicardipine hydrochloride5,198,226Mar 30, 2010


Subscribe to Free Drug Patent Expiration Updates

Enter your email address:  
Also available in a Drug Patent Expiration NewsletterRSS feed and on Twitter

 

 

Drug patent expirations by month

Drug patent expirations by year

Number of drug patents per pharmaceutical drug 		Number of drugs per drug company

Most patents listed last year

Number of drug patents by drug company 		Number of pharmaceutical patent expirations faced by drug companies

Number of approved drugs produced per company

Top selling drugs

Database Preview

[ Home | Site Tour | Free Patent Expiration Newsletter | Affiliate Program | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
Bookmark or Share This Page ...
[del.icio.us] [Digg] [Google] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Yahoo!] [Email]